Clinical Trial Update: Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II) [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating sequential administration of oral 6-thioguanine after methotrexate in patients with relapsed Hodgkin lymphoma; the trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• 6-thioguanine (6-thioguanine)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Hodgkin's Disease | Phase 2 | Status: COMPLETED